The free radical hypothesis in idiopathic parkinsonism: Evidence against it
- 1 December 1992
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 32 (6) , 799-803
- https://doi.org/10.1002/ana.410320615
Abstract
The free radical hypothesis for the pathogenesis of idiopathic parkinsonism (Parkinson's disease) has many similarities to the argument invoking an autoimmune mechanism. In both cases, cellular and molecular machinery that might be involved in neuronal destruction have been demonstrated. In recent years, the free radical hypothesis has become particularly fashionable; several workers have reported observations which, they infer, support the notion that damage by free radicals is a major factor in the underlying disease process. There is, however, no conclusive evidence that free radicals play a prominent role in the causal chain of events that leads to idiopathic parkinsonism; several findings may be construed as evidence against such a contention.Keywords
This publication has 24 references indexed in Scilit:
- Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28KPublished by Elsevier ,2003
- The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomaticAnnals of Neurology, 1992
- Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's DiseaseJournal of Neurochemistry, 1992
- Neuronal inclusions of Parkinson's diseaseMovement Disorders, 1991
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- Ubiquitin deposits in anterior horn cells in motor neurone diseaseNeuroscience Letters, 1988
- IN PRAISE OF PEROXIDATIONThe Lancet, 1988
- Rate of cell death in parkinsonism indicates active neuropathological processAnnals of Neurology, 1988
- Preservation of the substanitia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four‐year periodMovement Disorders, 1986